Ethyl β-carboline-3-carboxylate

Ethyl β-carboline-3-carboxylate (β-CCE) is a short-acting benzodiazepine receptor antagonist. While it does not alter cerebellar cGMP levels alone, it potently inhibits the cGMP elevation induced by diazepam. This compound is a valuable research tool for investigating GABA_A receptor pharmacology and benzodiazepine antagonist effects in both in vitro and in vivo neurological studies.